WallStSmart

Brookfield Asset Management Inc (BAM)vsCohen & Steers Inc (CNS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Brookfield Asset Management Inc generates 766% more annual revenue ($4.82B vs $556.12M). BAM leads profitability with a 51.6% profit margin vs 27.6%. CNS appears more attractively valued with a PEG of 0.98. BAM earns a higher WallStSmart Score of 66/100 (B-).

BAM

Strong Buy

66

out of 100

Grade: B-

Growth: 6.7Profit: 9.0Value: 7.3Quality: 6.0
Piotroski: 3/9

CNS

Buy

59

out of 100

Grade: C

Growth: 2.7Profit: 9.5Value: 7.3Quality: 4.8
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BAMSignificantly Overvalued (-400.1%)

Margin of Safety

-400.1%

Fair Value

$10.47

Current Price

$42.87

$32.40 premium

UndervaluedFair: $10.47Overvalued
CNSSignificantly Overvalued (-220.9%)

Margin of Safety

-220.9%

Fair Value

$20.20

Current Price

$61.90

$41.70 premium

UndervaluedFair: $20.20Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAM5 strengths · Avg: 9.6/10
Profit MarginProfitability
51.6%10/10

Keeps 52 of every $100 in revenue as profit

Operating MarginProfitability
67.9%10/10

Strong operational efficiency at 67.9%

Revenue GrowthGrowth
31.1%10/10

Revenue surging 31.1% year-over-year

Market CapQuality
$70.28B9/10

Large-cap with strong market position

Return on EquityProfitability
22.3%9/10

Every $100 of equity generates 22 in profit

CNS4 strengths · Avg: 8.5/10
Return on EquityProfitability
26.0%9/10

Every $100 of equity generates 26 in profit

Profit MarginProfitability
27.6%9/10

Keeps 28 of every $100 in revenue as profit

PEG RatioValuation
0.988/10

Growing faster than its price suggests

Operating MarginProfitability
28.0%8/10

Strong operational efficiency at 28.0%

Areas to Watch

BAM4 concerns · Avg: 3.3/10
P/E RatioValuation
27.9x4/10

Moderate valuation

Price/BookValuation
8.5x4/10

Trading at 8.5x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-20.7%2/10

Earnings declined 20.7%

CNS3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
2.9%4/10

2.9% revenue growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-24.5%2/10

Earnings declined 24.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : BAM

The strongest argument for BAM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 51.6% and operating margin at 67.9%. Revenue growth of 31.1% demonstrates continued momentum.

Bull Case : CNS

The strongest argument for CNS centers on Return on Equity, Profit Margin, PEG Ratio. Profitability is solid with margins at 27.6% and operating margin at 28.0%. PEG of 0.98 suggests the stock is reasonably priced for its growth.

Bear Case : BAM

The primary concerns for BAM are P/E Ratio, Price/Book, Piotroski F-Score.

Bear Case : CNS

The primary concerns for CNS are Revenue Growth, Piotroski F-Score, EPS Growth.

Key Dynamics to Monitor

BAM profiles as a growth stock while CNS is a value play — different risk/reward profiles.

BAM carries more volatility with a beta of 1.29 — expect wider price swings.

BAM is growing revenue faster at 31.1% — sustainability is the question.

BAM generates stronger free cash flow (706M), providing more financial flexibility.

Bottom Line

BAM scores higher overall (66/100 vs 59/100), backed by strong 51.6% margins and 31.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Brookfield Asset Management Inc

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Brookfield Asset Management is a leading global alternative asset manager and one of the largest investors in real assets.

Visit Website →

Cohen & Steers Inc

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Cohen & Steers, Inc. is a publicly owned asset management portfolio company. The company is headquartered in New York, with additional offices in London, United Kingdom; Central, Hong Kong; Tokyo, Japan; and Seattle, Washington.

Visit Website →

Want to dig deeper into these stocks?